| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 222.50M | 160.10M | 129.70M | 155.70M | 219.20M |
| Gross Profit | 200.00M | 92.00M | 61.50M | 69.90M | 157.80M |
| EBITDA | 31.40M | 5.40M | -10.30M | 4.10M | 82.00M |
| Net Income | 46.00M | 8.60M | -38.30M | -6.90M | 61.20M |
Balance Sheet | |||||
| Total Assets | 535.90M | 358.00M | 373.20M | 384.00M | 565.90M |
| Cash, Cash Equivalents and Short-Term Investments | 447.00M | 187.60M | 290.00M | 246.80M | 375.30M |
| Total Debt | 273.60M | 109.50M | 69.50M | 66.10M | 237.40M |
| Total Liabilities | 307.50M | 141.50M | 126.40M | 100.00M | 277.90M |
| Stockholders Equity | 228.40M | 216.50M | 246.80M | 284.00M | 288.00M |
Cash Flow | |||||
| Free Cash Flow | -34.40M | -70.30M | -37.70M | -24.30M | 90.70M |
| Operating Cash Flow | -33.80M | -67.40M | -25.60M | -10.40M | 100.10M |
| Investing Cash Flow | -126.20M | 23.30M | 66.40M | 162.00M | 310.90M |
| Financing Cash Flow | 124.70M | 10.20M | 3.70M | -201.70M | -291.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £43.02M | 7.25 | 8.28% | ― | 5.19% | 14.53% | |
68 Neutral | £243.00M | 6.11 | 33.54% | 4.74% | 34.56% | 89.25% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £93.53M | 6.12 | 12.38% | ― | 18.38% | 13.20% | |
62 Neutral | £12.17M | 4.04 | 14.61% | 3.33% | 8.91% | 94.32% | |
58 Neutral | £12.89M | 7.41 | ― | ― | 35.19% | ― | |
55 Neutral | £421.51M | 9.67 | 21.54% | ― | 37.60% | 2766.67% |